Biotech · Private company
Five Prime Therapeutics, Inc.
Track this companyFree. Adds Five Prime Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials70 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- BemarituzumabPhase 2 · Gastric CancerClinicalTrials.gov · fetched Nov 12, 2026
- FPA008Phase 2 · Pigmented Villonodular SynovitisClinicalTrials.gov · fetched Nov 12, 2026
- Modified FOLFOX6Phase 2 · Gastric CancerClinicalTrials.gov · fetched Nov 12, 2026
- BemarituzumabPhase 1 · Gastrointestinal CancerClinicalTrials.gov · fetched Nov 12, 2026
- CabiralizumabPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- FP-1039Phase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- FPA144Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- FPA150Phase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Modified FOLFOX6Phase 1 · Gastrointestinal CancerClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction CancerPHASE2 · COMPLETED · started Sep 14, 2018ClinicalTrials.gov NCT03694522 · fetched Nov 12, 2026
- FPA150 in Patients With Advanced Solid TumorsEARLY_PHASE1 · TERMINATED · started Mar 27, 2018ClinicalTrials.gov NCT03514121 · fetched Nov 12, 2026
- A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal CancerPHASE1 · COMPLETED · started Nov 30, 2017ClinicalTrials.gov NCT03343301 · fetched Nov 12, 2026
- Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced CancersPHASE1 · COMPLETED · started Sep 8, 2015ClinicalTrials.gov NCT02526017 · fetched Nov 12, 2026
- Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell TumorPHASE1_PHASE2 · COMPLETED · started Jun 1, 2015ClinicalTrials.gov NCT02471716 · fetched Nov 12, 2026
- Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Nov 1, 2014ClinicalTrials.gov NCT02318329 · fetched Nov 12, 2026
- Safety Study of FP-1039 To Treat CancerPHASE1 · COMPLETED · started Jul 1, 2008ClinicalTrials.gov NCT00687505 · fetched Nov 12, 2026